Could Glycated Hemoglobin be Leakage Predictor in Sleeve Gastrectomy? A Retrospective Observational Study on 4233 Patients.
Glycated hemoglobin
Leakage
Sleeve gastrectomy
Journal
Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
received:
17
04
2023
accepted:
14
07
2023
revised:
07
07
2023
medline:
18
8
2023
pubmed:
20
7
2023
entrez:
19
7
2023
Statut:
ppublish
Résumé
Diabetes increases the risks related to surgery. At the same time, bariatric surgery improves diabetes. Glycated hemoglobin (A1C) is an index of diabetes severity. The purpose of this study is to evaluate A1C as a possible predictor of postoperative complications after Sleeve Gastrectomy (SG), focusing on leakage. Monocentric retrospective study considering all consecutive patients with obesity, with or without diabetes, who underwent bariatric surgical procedures, from January 2018 to December 2021. All patients had preoperative A1C values. 4233 patients were considered. 522 patients (12.33%) were diabetics (A1C ≥ 6.5%). Of these, 260 patients (6.14%) had A1C ≥ 7% and 59 (1.39%) A1C ≥ 8%. 1718 patients (40.58%) were in a pre-diabetic range (A1C 5.7%-6.5%). Higher A1C values were associated with older age, male gender, higher BMI and increased rate of comorbidities. A longer operative time was observed for patients with A1C ≥ 7%, p = 0.027 (53 ± 20 vs 51 ± 18 min). The frequency of leakage was significantly higher when A1C ≥ 7% (3.8% vs 2.0%, p = 0.026). The frequency of leakage further increased when A1C ≥ 8% (5.1%), although this difference did not reach statistical significance. Patients with obesity and A1C ≥ 7% need to be referred to a diabetologist to treat diabetes before surgery and consequently decrease the risk of leakage.
Identifiants
pubmed: 37468702
doi: 10.1007/s11695-023-06754-5
pii: 10.1007/s11695-023-06754-5
doi:
Substances chimiques
Glycated Hemoglobin
0
Types de publication
Observational Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2851-2858Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Whiting DR, Guariguata L, Weil C, et al. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94(3):311–21.
doi: 10.1016/j.diabres.2011.10.029
pubmed: 22079683
Poulsen P, Kyvik KO, Vaag A, et al. Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance–a population-based twin study. Diabetologia. 1999;42(2):139–45.
doi: 10.1007/s001250051131
pubmed: 10064092
Nguyen NT, Nguyen XM, Lane J, et al. Relationship between obesity and diabetes in a US adult population: findings from the National Health and Nutrition Examination Survey, 1999–2006. Obes Surg. 2011;21(3):351–5.
doi: 10.1007/s11695-010-0335-4
pubmed: 21128002
Sjöström L, Peltonen M, Jacobson P, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA. 2014;311:2297–304.
doi: 10.1001/jama.2014.5988
pubmed: 24915261
Brethauer SA, Aminian A, Romero-Talamás H, et al. Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg. 2013;258:628–37.
doi: 10.1097/SLA.0b013e3182a5034b
pubmed: 24018646
Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes. N Engl J Med. 2017;376(7):641–51.
doi: 10.1056/NEJMoa1600869
pubmed: 28199805
pmcid: 5451258
Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2015;386:964–73.
doi: 10.1016/S0140-6736(15)00075-6
pubmed: 26369473
Halperin F, Ding SA, Simonson DC, et al. Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial. JAMA Surg. 2014;149:716–26.
doi: 10.1001/jamasurg.2014.514
pubmed: 24899464
pmcid: 4274782
Courcoulas AP, Belle SH, Neiberg RH, et al. Three-year outcomes of bariatric surgery vs lifestyle intervention for type 2 diabetes mellitus treatment: a randomized clinical trial. JAMA Surg. 2015;150:931–40.
doi: 10.1001/jamasurg.2015.1534
pubmed: 26132586
pmcid: 4905566
Wentworth JM, Playfair J, Laurie C, et al. Multidisciplinary diabetes care with and without bariatric surgery in overweight people: a randomised controlled trial. Lancet Diabetes Endocrinol. 2014;2:545–52.
doi: 10.1016/S2213-8587(14)70066-X
pubmed: 24731535
Parikh M, Chung M, Sheth S, et al. Randomized pilot trial of bariatric surgery versus intensive medical weight management on diabetes remission in type 2 diabetic patients who do NOT meet NIH criteria for surgery and the role of soluble RAGE as a novel biomarker of success. Ann Surg. 2014;260:617–24.
doi: 10.1097/SLA.0000000000000919
pubmed: 25203878
Cummings DE, Arterburn DE, Westbrook EO, et al. Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial. Diabetologia. 2016;59:945–53.
doi: 10.1007/s00125-016-3903-x
pubmed: 26983924
pmcid: 4826815
Brito JP, Montori VM, Davis AM. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. JAMA. 2017;317(6):635–6.
doi: 10.1001/jama.2016.20563
pubmed: 28196240
pmcid: 5557277
Tan DJH, Yaow CYL, Mok HT, et al. The influence of diabetes on postoperative complications following colorectal surgery. Tech Coloproctol. 2021;25(3):267–78.
doi: 10.1007/s10151-020-02373-9
pubmed: 33386511
pmcid: 7775741
Reudink M, Slooter CD, Janssen L, et al. Metabolic syndrome; associations with adverse outcome after colorectal surgery. A systematic review and meta-analysis. Ann Med Surg (Lond). 2021;71:102997.
doi: 10.1016/j.amsu.2021.102997
pubmed: 34840752
Martin ET, Kaye KS, Knott C, et al. Diabetes and risk of surgical site infection: a systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2016;37(1):88–99.
doi: 10.1017/ice.2015.249
pubmed: 26503187
Meister KM, Hufford T, Tu C, et al. Clinical significance of perioperative hyperglycemia in bariatric surgery: evidence for better perioperative glucose management. Surg Obes Relat Dis. 2018;14(11):1725–31.
doi: 10.1016/j.soard.2018.07.028
pubmed: 30245036
Wong JKL, Ke Y, Ong YJ, et al. Impact of preoperative HbA1c on postoperative complications after elective major abdominal surgery: a systematic review protocol. BMJ Open. 2020;10(9): e039422.
doi: 10.1136/bmjopen-2020-039422
pubmed: 32998928
pmcid: 7528368
Underwood P, Askari R, Hurwitz S, et al. Preoperative A1C and clinical outcomes in patients with diabetes undergoing major noncardiac surgical procedures. Diabetes Care. 2014;37(3):611–6.
doi: 10.2337/dc13-1929
pubmed: 24170760
Mechanick JI, Apovian C, Brethauer S, et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures - 2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, the Obesity Society, American Society for Metabolic and Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists. Obesity (Silver Spring). 2020;28(4):O1–58.
doi: 10.1002/oby.22719
pubmed: 32202076
Basishvili G, Yang J, Nie L, et al. HbA1C is not directly associated with complications of bariatric surgery. Surg Obes Relat Dis. 2021;17(2):271–5.
doi: 10.1016/j.soard.2020.10.009
pubmed: 33243668
Sridhar N, Hetzel E, Kindel TL, et al. The Impact of hemoglobin A1c on post-operative outcomes in bariatric surgery patients. J Surg Res. 2021;267:636–41.
doi: 10.1016/j.jss.2021.06.022
pubmed: 34273793
Aiolfi A, Gagner M, Zappa MA, et al. Staple line reinforcement during laparoscopic sleeve gastrectomy: systematic review and network meta-analysis of randomized controlled trials. Obes Surg. 2022;32(5):1466–78.
doi: 10.1007/s11695-022-05950-z
pubmed: 35169954
pmcid: 8986671
Cesana G, Cioffi S, Giorgi R, et al. Proximal leakage after laparoscopic sleeve gastrectomy: an analysis of preoperative and operative predictors on 1738 consecutive procedures. Obes Surg. 2018;28(3):627–35.
doi: 10.1007/s11695-017-2907-z
pubmed: 28840492
von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. Int J Surg. 2014;12:1495–9.
doi: 10.1016/j.ijsu.2014.07.013
American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S15–33 (Erratum in: Diabetes Care. 2021 Sep;44(9):2182).
doi: 10.2337/dc21-S002
Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25(6):1105–87 (Erratum in: J Hypertens. 2007 Aug;25(8):1749).
doi: 10.1097/HJH.0b013e3281fc975a
pubmed: 17563527
Olmi S, Uccelli M, Cesana GC, et al. Modified laparoscopic sleeve gastrectomy with Rossetti antireflux fundoplication: results after 220 procedures with 24-month follow-up. Surg Obes Relat Dis. 2020;16(9):1202–11.
doi: 10.1016/j.soard.2020.03.029
pubmed: 32423830
Olmi S, Cesana G, D’Angiolella L, et al. Sleeve gastrectomy with tailored 360° fundoplication according to Rossetti in patients affected by obesity and gastroesophageal reflux: a prospective observational study. Surg Obes Relat Dis. 2021;17(6):1057–65.
doi: 10.1016/j.soard.2021.01.007
pubmed: 33622604
Iliodromiti S, McLaren J, Ghouri N, et al. Liver, visceral and subcutaneous fat in men and women of South Asian and white European descent: a systematic review and meta-analysis of new and published data. Diabetologia. 2023;66(1):44–56.
doi: 10.1007/s00125-022-05803-5
pubmed: 36224274
Olmi S, Cesana G, Gambioli A, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic sleeve + Rossetti fundoplication on weight loss and de novo GERD in patients affected by morbid obesity: a randomized clinical study. Obes Surg. 2022;32(5):1451–8.
doi: 10.1007/s11695-022-05955-8
pubmed: 35137287
pmcid: 9055016